European heart journal. Acute cardiovascular care. 2022 Oct 13. pii: 6759859. doi: 10.1093/ehjacc/zuac107 |
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias. |
Gevaert SA1, Halvorsen S2, Sinnaeve PR3, Sambola A4, Gulati G5, Lancellotti P6, Van Der Meer P7, Lyon AR8, Farmakis D9, Lee G10, Boriani G11, Wechalekar A12, Okines A13, Asteggiano R14, Combes A15, Pfister R16, Bergler-Klein J17, Lettino M18 |
Abstract Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the population have led to an increasing number of cancer patients presenting with acute CV diseases. These events may be related to cancer itself or cancer treatment. Acute cardiac care specialists must be aware of these acute CV complications and be able to manage them. This may require an individualized and multidisciplinary approach. The management of acute coronary syndromes and acute pericardial diseases in cancer patients was covered in part 1 of a clinical consensus document. This second part focusses on acute heart failure, acute myocardial diseases, venous thromboembolic diseases and acute arrhythmias. |
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com. |
KEYWORDS: Acute heart failure, Acute toxicity, Arrhythmia, Cancer, Cardiac implanted electronic devices (CIED), Cardiotoxicity, Myocarditis, Pulmonary embolism, Takotsubo syndrome, Venous thromboembolic disease |
Publikations ID: 36226746 Quelle: öffnen |